-transparent.png){kind=logo}
A series of amine cyanoboranes and amine carboxyboranes were observed to be antihyperlipidemic agents in mice; i.e., they lowered serum cholesterol and triglyceride levels significantly. These compounds appeared to inhibit lipid synthesis in the early stages. The ability to lower serum cholesterol levels appeared to correlate with the suppression of the regulatory enzyme of cholesterol synthesis, beta-hydroxy-beta-methylglutaryl-CoA reductase activity. The reduction of serum triglycerides correlated with ability of the borane compound to suppress liver fatty acid synthetase activity.
Related Publications
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
January 1995,
Archiv der Pharmazie,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
June 1980,
Journal of pharmaceutical sciences,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
January 1995,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
January 1994,
Metal-based drugs,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
July 1991,
Archiv der Pharmazie,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
May 1998,
Archiv der Pharmazie,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
November 1994,
Environmental health perspectives,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
November 2004,
Mini reviews in medicinal chemistry,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
August 1991,
Die Pharmazie,
I H Hall, and
M K Das, and
F Harchelroad, and
P Wisian-Neilson, and
A T McPhail, and
B F Spielvogel
December 1990,
Anti-cancer drugs,
